These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1794189)

  • 1. Skin morphology in porphyria cutanea tarda does not improve despite clinical remission.
    Timonen K; Niemi KM; Mustajoki P
    Clin Exp Dermatol; 1991 Sep; 16(5):355-8. PubMed ID: 1794189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver changes in porphyria cutanea tarda patients treated with chloroquine.
    Chlumska A; Chlumsky J; Malina L
    Br J Dermatol; 1980 Mar; 102(3):261-6. PubMed ID: 7370174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose oral chloroquine in the treatment of porphyria cutanea tarda.
    Ashton RE; Hawk JL; Magnus IA
    Br J Dermatol; 1984 Nov; 111(5):609-13. PubMed ID: 6498093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Major hypertrichosis in an adult female secondary to porphyria cutanea tarda. Its evolution with chloroquine].
    Michel B; Guillot B; Guilhou JJ; Meynadier J
    Ann Dermatol Venereol; 1983; 110(4):361-3. PubMed ID: 6625460
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of chloroquine in porphyria cutanea tarda].
    Herrero C; Muniesa A
    Med Cutan Ibero Lat Am; 1980; 8(4-6):139-45. PubMed ID: 7024672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The morphology of skin damage in porphyria cutanea tarda (PCT)].
    Kemmer C; Reitmann I; Köstler E; Riedel H
    Zentralbl Allg Pathol; 1988; 134(3):227-34. PubMed ID: 3055747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of porphyria cutanea tarda with intermittent chloroquine].
    Raff M; Formanek I
    Hautarzt; 1980 Aug; 31(8):437-40. PubMed ID: 7451150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desferrioxamine in the treatment of porphyria cutanea tarda: ineffectiveness of intramuscular administration.
    Muñoz JJ; Garcia-Cabezas J; Martinez-Verano J; Perez-Oteyza C; Enriquez de Salamanca R
    J Dermatol; 1990 May; 17(5):329-31. PubMed ID: 2380437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effect of high-dose, short-course chloroquine therapy on porphyria cutanea tarda.
    Tsega E
    Q J Med; 1987 Nov; 65(247):953-7. PubMed ID: 3455550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The morphologic events of blister formation in porphyria cutanea tarda.
    Caputo R; Berti E; Gasparini G; Monti M
    Int J Dermatol; 1983 Oct; 22(8):467-72. PubMed ID: 6358065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic and pathogenetic aspects of porphyria cutanea tarda].
    Köstler E; Seebacher C; Riedel H; Kemmer C
    Hautarzt; 1986 Apr; 37(4):210-6. PubMed ID: 3009356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The liver in Ethiopians with porphyria cutanea tarda.
    Tsega E; Damtew B; Landells JW; Besrat A; Seyoum E
    East Afr Med J; 1982 Oct; 59(10):682-8. PubMed ID: 7185559
    [No Abstract]   [Full Text] [Related]  

  • 13. [Mechanism of bullous formation in porphyria cutanea tarda. 1. Histopathological observation of bullae in 3 cases of porphyria cutanea tarda].
    Nagato N; Ohgami T; Murayama F; Honda T; Nonaka S; Yoshida H
    Nihon Hifuka Gakkai Zasshi; 1987 Mar; 97(4):471-7. PubMed ID: 3613213
    [No Abstract]   [Full Text] [Related]  

  • 14. Mechanisms of phototoxicity in porphyria cutanea tarda and erythropoietic protoporphyria.
    Lim HW
    Immunol Ser; 1989; 46():671-85. PubMed ID: 2488874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Porphyria cutanea tarda and pregnancy.
    Goerz G; Hammer G
    Dermatologica; 1983 Jun; 166(6):316-8. PubMed ID: 6884554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxychloroquine treatment of porphyria cutanea tarda.
    Malkinson FD; Levitt L
    Arch Dermatol; 1980 Oct; 116(10):1147-50. PubMed ID: 7425660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Porphyria cutanea tarda simulating scleroderma.
    Goh CL
    Singapore Med J; 1987 Feb; 28(1):83-8. PubMed ID: 3603082
    [No Abstract]   [Full Text] [Related]  

  • 18. Porphyria cutanea tarda. Remission following chloroquine administration without adverse effects.
    Saltzer EI; Redeker AG; Wilson JW
    Arch Dermatol; 1968 Nov; 98(5):496-8. PubMed ID: 5693347
    [No Abstract]   [Full Text] [Related]  

  • 19. [Iron metabolism and chloroquine phosphate therapy in porphyria cutanea tarda].
    Köstler E; Pollack P; Seebacher C; Riedel H
    Z Hautkr; 1990 Nov; 65(11):1030-2, 1035. PubMed ID: 2080653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Porphyria cutanea tarda (chronic hepatic porphyria): new aspects on pathogenesis, diagnosis and therapy with a review of the workshop, "Cutaneous porphyrias" at the 17th World Congress of Dermatology in Berlin 1987].
    Doss MO
    Z Hautkr; 1988 Apr; 63(4):282-9. PubMed ID: 3291437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.